Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study

Introduction This study aimed to investigate and compare the therapeutic efficacy and safety of ultrasound-guided radiofrequency ablation (RFA), between primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism (SHPT) patients, with or without previous parathyroidectomy (PTX).Subjects and...

Full description

Bibliographic Details
Main Authors: Chi-Cheng Chen, Hsiu-Ling Chen, Pi-Ling Chiang, Sheng-Dean Luo, Yen-Hsiang Chang, Wei-Chih Chen, Cheng-Kang Wang, An-Ni Lin, Yueh-Sheng Chen, Shun-Yu Chi, Wei-Che Lin
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2022.2097324
_version_ 1818097331999866880
author Chi-Cheng Chen
Hsiu-Ling Chen
Pi-Ling Chiang
Sheng-Dean Luo
Yen-Hsiang Chang
Wei-Chih Chen
Cheng-Kang Wang
An-Ni Lin
Yueh-Sheng Chen
Shun-Yu Chi
Wei-Che Lin
author_facet Chi-Cheng Chen
Hsiu-Ling Chen
Pi-Ling Chiang
Sheng-Dean Luo
Yen-Hsiang Chang
Wei-Chih Chen
Cheng-Kang Wang
An-Ni Lin
Yueh-Sheng Chen
Shun-Yu Chi
Wei-Che Lin
author_sort Chi-Cheng Chen
collection DOAJ
description Introduction This study aimed to investigate and compare the therapeutic efficacy and safety of ultrasound-guided radiofrequency ablation (RFA), between primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism (SHPT) patients, with or without previous parathyroidectomy (PTX).Subjects and Methods A total of 21 patients (7 PHPT, 14 SHPT) underwent RFA for hyperparathyroidism (HPT) at Kaohsiung Chang Gung Memorial Hospital, Taiwan. Five of the 14 SHPT patients had previously received PTX. The laboratory data, volume change of each parathyroid nodule, symptomatic scores, and complications were analyzed and compared between all groups at 1 and 7 days, and at 1, 3, 6, and 12 months after RFA.Results After RFA, the volume reduction ratio (VRR) for all patients at the last follow-up was 93.76%, and clinical symptoms significantly improved. At 12 months, all PHPT patients achieved successful treatment of intact PTH (iPTH). In SHPT patients, the mean iPTH value significantly decreased 1-day post-RFA, subsequently exhibiting a transient rebound which proceeded to decrease, with 57.1% reaching successful treatment standards. SHPT patients with PTX showed a lower complication score, shorter ablation time, higher iPTH baseline and outcomes, and lower VRR, compared to patients without PTX. The serum calcium level significantly decreased to normal range in 85.7% of all patients at 12 months. Severe hypocalcemia occurred in 23.8% at 1 week, and all were corrected with calcium supplements.Conclusions RFA demonstrates a therapeutic efficacy similar to PTX. It can thus be considered an effective alternative treatment for PHPT, SHPT, or post-PTX patients who are unsuitable for another PTX.
first_indexed 2024-12-10T23:18:50Z
format Article
id doaj.art-52f7cb079a8f4c81ab2e2c1edfc0def7
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-12-10T23:18:50Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-52f7cb079a8f4c81ab2e2c1edfc0def72022-12-22T01:29:47ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572022-12-0139190791710.1080/02656736.2022.2097324Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective studyChi-Cheng Chen0Hsiu-Ling Chen1Pi-Ling Chiang2Sheng-Dean Luo3Yen-Hsiang Chang4Wei-Chih Chen5Cheng-Kang Wang6An-Ni Lin7Yueh-Sheng Chen8Shun-Yu Chi9Wei-Che Lin10Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartments of Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanDepartment of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, TaiwanIntroduction This study aimed to investigate and compare the therapeutic efficacy and safety of ultrasound-guided radiofrequency ablation (RFA), between primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism (SHPT) patients, with or without previous parathyroidectomy (PTX).Subjects and Methods A total of 21 patients (7 PHPT, 14 SHPT) underwent RFA for hyperparathyroidism (HPT) at Kaohsiung Chang Gung Memorial Hospital, Taiwan. Five of the 14 SHPT patients had previously received PTX. The laboratory data, volume change of each parathyroid nodule, symptomatic scores, and complications were analyzed and compared between all groups at 1 and 7 days, and at 1, 3, 6, and 12 months after RFA.Results After RFA, the volume reduction ratio (VRR) for all patients at the last follow-up was 93.76%, and clinical symptoms significantly improved. At 12 months, all PHPT patients achieved successful treatment of intact PTH (iPTH). In SHPT patients, the mean iPTH value significantly decreased 1-day post-RFA, subsequently exhibiting a transient rebound which proceeded to decrease, with 57.1% reaching successful treatment standards. SHPT patients with PTX showed a lower complication score, shorter ablation time, higher iPTH baseline and outcomes, and lower VRR, compared to patients without PTX. The serum calcium level significantly decreased to normal range in 85.7% of all patients at 12 months. Severe hypocalcemia occurred in 23.8% at 1 week, and all were corrected with calcium supplements.Conclusions RFA demonstrates a therapeutic efficacy similar to PTX. It can thus be considered an effective alternative treatment for PHPT, SHPT, or post-PTX patients who are unsuitable for another PTX.https://www.tandfonline.com/doi/10.1080/02656736.2022.2097324Radiofrequency ablationhyperplastic parathyroid glandsecondary hyperparathyroidismultrasound guidedparathyroidectomy
spellingShingle Chi-Cheng Chen
Hsiu-Ling Chen
Pi-Ling Chiang
Sheng-Dean Luo
Yen-Hsiang Chang
Wei-Chih Chen
Cheng-Kang Wang
An-Ni Lin
Yueh-Sheng Chen
Shun-Yu Chi
Wei-Che Lin
Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
International Journal of Hyperthermia
Radiofrequency ablation
hyperplastic parathyroid gland
secondary hyperparathyroidism
ultrasound guided
parathyroidectomy
title Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
title_full Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
title_fullStr Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
title_full_unstemmed Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
title_short Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study
title_sort efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy a retrospective study
topic Radiofrequency ablation
hyperplastic parathyroid gland
secondary hyperparathyroidism
ultrasound guided
parathyroidectomy
url https://www.tandfonline.com/doi/10.1080/02656736.2022.2097324
work_keys_str_mv AT chichengchen efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT hsiulingchen efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT pilingchiang efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT shengdeanluo efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT yenhsiangchang efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT weichihchen efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT chengkangwang efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT annilin efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT yuehshengchen efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT shunyuchi efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy
AT weichelin efficacyandsafetyofradiofrequencyablationforprimaryandsecondaryhyperparathyroidismwithorwithoutpreviousparathyroidectomyaretrospectivestudy